Marks MJ - Search Results

1

Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.

Quik M, Sum JD, Whiteaker P, McCallum SE, Marks MJ, Musachio J, McIntosh JM, Collins AC, Grady SR. Quik M, et al. Among authors: marks mj. Mol Pharmacol. 2003 May;63(5):1169-79. doi: 10.1124/mol.63.5.1169. Mol Pharmacol. 2003. PMID: 12695545

2

L-DOPA treatment modulates nicotinic receptors in monkey striatum.

Quik M, Bordia T, Okihara M, Fan H, Marks MJ, McIntosh JM, Whiteaker P. Quik M, et al. Among authors: marks mj. Mol Pharmacol. 2003 Sep;64(3):619-28. doi: 10.1124/mol.64.3.619. Mol Pharmacol. 2003. PMID: 12920198

3

Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR. Salminen O, et al. Among authors: marks mj. Mol Pharmacol. 2004 Jun;65(6):1526-35. doi: 10.1124/mol.65.6.1526. Mol Pharmacol. 2004. PMID: 15155845

4

Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.

Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, Whiteaker P. Gotti C, et al. Among authors: marks mj. Mol Pharmacol. 2005 Jun;67(6):2007-15. doi: 10.1124/mol.105.011940. Epub 2005 Mar 4. Mol Pharmacol. 2005. PMID: 15749993

5

Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.

Marks MJ, Whiteaker P, Collins AC. Marks MJ, et al. Mol Pharmacol. 2006 Sep;70(3):947-59. doi: 10.1124/mol.106.025338. Epub 2006 May 25. Mol Pharmacol. 2006. PMID: 16728647

6

Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.

Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. Salminen O, et al. Among authors: marks mj. Mol Pharmacol. 2007 Jun;71(6):1563-71. doi: 10.1124/mol.106.031492. Epub 2007 Mar 6. Mol Pharmacol. 2007. PMID: 17341654

7

125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.

Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ. Whiteaker P, et al. Among authors: marks mj. Mol Pharmacol. 2000 May;57(5):913-25. Mol Pharmacol. 2000. PMID: 10779374

8

A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function.

Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. Dobelis P, et al. Among authors: marks mj. Mol Pharmacol. 2002 Aug;62(2):334-42. doi: 10.1124/mol.62.2.334. Mol Pharmacol. 2002. PMID: 12130686

9

Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.

Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. Mogg AJ, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):197-204. doi: 10.1124/jpet.302.1.197. J Pharmacol Exp Ther. 2002. PMID: 12065717

10

Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.

Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Grady SR, et al. Among authors: marks mj. J Pharmacol Exp Ther. 2002 May;301(2):651-60. doi: 10.1124/jpet.301.2.651. J Pharmacol Exp Ther. 2002. PMID: 11961070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters